Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 2/2009

01.11.2009

Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia

verfasst von: A. T. Gloster, H. U. Wittchen, F. Einsle, M. Höfler, T. Lang, S. Helbig-Lang, T. Fydrich, L. Fehm, A. O. Hamm, J. Richter, G. W. Alpers, A. L. Gerlach, A. Ströhle, T. Kircher, J. Deckert, P. Zwanzger, V. Arolt

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Sonderheft 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Cognitive behavioral therapy (CBT) is efficacious for panic disorder with agoraphobia (PD/A). Nevertheless, the active ingredients of treatment and the mechanisms through which CBT achieves its effects remain largely unknown. The mechanisms of action in CBT (MAC) study was established to investigate these questions in 369 patients diagnosed with PD/A. The MAC study utilized a multi-center, randomized controlled design, with two active treatment conditions in which the administration of exposure was varied, and a wait-list control group. The special feature of MAC is the way in which imbedded experimental, psychophysiological, and neurobiological paradigms were included to elucidate therapeutic and psychopathological processes. This paper describes the aims and goals of the MAC study and the methods utilized to achieve them. All aspects of the research design (e.g., assessments, treatment, experimental procedures) were implemented so as to facilitate the detection of active therapeutic components, and the mediators and moderators of therapeutic change. To this end, clinical, behavioral, physiological, experimental, and genetic data were collected and will be integrated.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Alpers GW, Sell R (2008) And yet they correlate: psychophysiological measures predict the outcome of exposure therapy in claustrophobia. J Anxiety Disord 22:1101–1109CrossRefPubMed Alpers GW, Sell R (2008) And yet they correlate: psychophysiological measures predict the outcome of exposure therapy in claustrophobia. J Anxiety Disord 22:1101–1109CrossRefPubMed
2.
Zurück zum Zitat American Psychiatric Association (2000) Diagnostic and statistic manual of mental disorders, text revision, 4th edn. American Psychiatric Association, Washington, DCCrossRef American Psychiatric Association (2000) Diagnostic and statistic manual of mental disorders, text revision, 4th edn. American Psychiatric Association, Washington, DCCrossRef
3.
Zurück zum Zitat Andor F, Glöckner-Rist A, Gerlach AL, Rist F (2008) Symptomspezifische Subgruppen der Panikstörung. Zeitschrift für Klinische Psychologie und Psychotherapie 37:161–171CrossRef Andor F, Glöckner-Rist A, Gerlach AL, Rist F (2008) Symptomspezifische Subgruppen der Panikstörung. Zeitschrift für Klinische Psychologie und Psychotherapie 37:161–171CrossRef
4.
Zurück zum Zitat Arch JJ, Craske MG (2008) Acceptance and commitment therapy and cognitive behavioral therapy for anxiety disorders: different treatments, similar mechanisms? Clin Psychol Sci Pract 15:263–279 Arch JJ, Craske MG (2008) Acceptance and commitment therapy and cognitive behavioral therapy for anxiety disorders: different treatments, similar mechanisms? Clin Psychol Sci Pract 15:263–279
5.
Zurück zum Zitat Arch JJ, Craske MG (2009) First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives. Psychiatr Clin North America 32:525–547CrossRef Arch JJ, Craske MG (2009) First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives. Psychiatr Clin North America 32:525–547CrossRef
6.
Zurück zum Zitat Baker-Morrissette S, Spiegel DA, Heinrichs N (2005) Sensation-focused intensive treatment for panic disorder with moderate to severe agoraphobia. Cogn Behav Pract 12:17–29CrossRef Baker-Morrissette S, Spiegel DA, Heinrichs N (2005) Sensation-focused intensive treatment for panic disorder with moderate to severe agoraphobia. Cogn Behav Pract 12:17–29CrossRef
7.
Zurück zum Zitat Bandelow B (1999) Panic and agoraphobia scale (PAS). Hogrefe & Huber Publishers, Ashland Bandelow B (1999) Panic and agoraphobia scale (PAS). Hogrefe & Huber Publishers, Ashland
8.
Zurück zum Zitat Barlow DH, Gorman JM, Shear MK, Woods SW (2000) Cognitive-behavioral therapy, imipramine, or their combination for panic disorder—a randomized controlled trial. JAMA 283:2529–2536CrossRefPubMed Barlow DH, Gorman JM, Shear MK, Woods SW (2000) Cognitive-behavioral therapy, imipramine, or their combination for panic disorder—a randomized controlled trial. JAMA 283:2529–2536CrossRefPubMed
9.
Zurück zum Zitat Beck AT, Steer RA, Brown GK (1996) Manual for the BDI-II. The Psychological Corporation, San Antonio Beck AT, Steer RA, Brown GK (1996) Manual for the BDI-II. The Psychological Corporation, San Antonio
10.
Zurück zum Zitat Blümel I, Jansen A, Kellermann T, Schüppen A, Kohn N, Gerlach A et al. (2009) Neural correlates of aversive conditioning (submitted) Blümel I, Jansen A, Kellermann T, Schüppen A, Kohn N, Gerlach A et al. (2009) Neural correlates of aversive conditioning (submitted)
11.
Zurück zum Zitat Bond FW, Hayes SC, Baer RA, Carpenter KM, Orcutt HK, Waltz T et al. (2007) Preliminary psychometric properties of the acceptance and action questionnaire—II: a revised measure of psychological flexibility and acceptance (in review) Bond FW, Hayes SC, Baer RA, Carpenter KM, Orcutt HK, Waltz T et al. (2007) Preliminary psychometric properties of the acceptance and action questionnaire—II: a revised measure of psychological flexibility and acceptance (in review)
12.
13.
Zurück zum Zitat Chambless DL, Caputo GC, Bright P, Gallagher R (1984) Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 52:1090–1097CrossRefPubMed Chambless DL, Caputo GC, Bright P, Gallagher R (1984) Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 52:1090–1097CrossRefPubMed
14.
Zurück zum Zitat Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395CrossRefPubMed Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395CrossRefPubMed
15.
Zurück zum Zitat Craske MG, Barlow DH (2007) Mastery of your anxiety and panic. University Press, Oxford Craske MG, Barlow DH (2007) Mastery of your anxiety and panic. University Press, Oxford
16.
Zurück zum Zitat Craske MG, Kircanski K, Zelikowsky M, Mystkowski J, Chowdhury N, Baker A (2008) Optimizing inhibitory learning during exposure therapy. Behav Res Ther 46:5–27CrossRefPubMed Craske MG, Kircanski K, Zelikowsky M, Mystkowski J, Chowdhury N, Baker A (2008) Optimizing inhibitory learning during exposure therapy. Behav Res Ther 46:5–27CrossRefPubMed
17.
Zurück zum Zitat Crawford JR, Henry JD (2004) The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. British Journal of Clinical Psychology 43:245–265CrossRefPubMed Crawford JR, Henry JD (2004) The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. British Journal of Clinical Psychology 43:245–265CrossRefPubMed
18.
Zurück zum Zitat Davis M (2006) Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol 61:741–756CrossRefPubMed Davis M (2006) Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol 61:741–756CrossRefPubMed
19.
Zurück zum Zitat Deckert J, Catalano M, Syagailo Y, Bosi M, Okladnova O, Di Bella D et al (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621–624CrossRefPubMed Deckert J, Catalano M, Syagailo Y, Bosi M, Okladnova O, Di Bella D et al (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621–624CrossRefPubMed
20.
Zurück zum Zitat Derogatis LR (1993) Brief symptom inventory (BSI) administration, scoring, and procedures manual, 3rd edn. National Computer Systems, Minneapolis Derogatis LR (1993) Brief symptom inventory (BSI) administration, scoring, and procedures manual, 3rd edn. National Computer Systems, Minneapolis
21.
Zurück zum Zitat Domschke K, Braun M, Ohrmann P, Suslow T, Kugel H, Bauer J et al (2006) Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal and amygdala activation measured with 3T fMRI in panic disorder. Int J Neuropsychopharmacol 9:349–355CrossRefPubMed Domschke K, Braun M, Ohrmann P, Suslow T, Kugel H, Bauer J et al (2006) Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal and amygdala activation measured with 3T fMRI in panic disorder. Int J Neuropsychopharmacol 9:349–355CrossRefPubMed
22.
Zurück zum Zitat Domschke K, Hohoff C, Jacob C, Maier W, Fritze J, Bandelow B et al (2008) Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. Am J Med Genet B Neuropsychiatr Genet 147B:510–516CrossRefPubMed Domschke K, Hohoff C, Jacob C, Maier W, Fritze J, Bandelow B et al (2008) Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. Am J Med Genet B Neuropsychiatr Genet 147B:510–516CrossRefPubMed
23.
Zurück zum Zitat Domschke K, Ohrmann P, Braun M, Suslow T, Bauer J, Hohoff C et al (2008) Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res 163:13–20CrossRefPubMed Domschke K, Ohrmann P, Braun M, Suslow T, Bauer J, Hohoff C et al (2008) Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res 163:13–20CrossRefPubMed
24.
Zurück zum Zitat Gloster A, Einsle F, Lang T, Hauke T, Wittchen H-U (2009) The therapist adherence and competency rating scales for panic disorder with agoraphobia (in preparation) Gloster A, Einsle F, Lang T, Hauke T, Wittchen H-U (2009) The therapist adherence and competency rating scales for panic disorder with agoraphobia (in preparation)
25.
Zurück zum Zitat Gloster AT, Klotsche J, Helbig S, Einsle F, Lang T, Hummel K et al. (2009) Expanding the assessment domain in agoraphobia: mobility inventory-expanded (MI-E) and mobility inventory 7-day (MI-7) versions (in preparation) Gloster AT, Klotsche J, Helbig S, Einsle F, Lang T, Hummel K et al. (2009) Expanding the assessment domain in agoraphobia: mobility inventory-expanded (MI-E) and mobility inventory 7-day (MI-7) versions (in preparation)
26.
Zurück zum Zitat Gorman JM, Kent JM, Sullivan GM, Coplan JD (2000) Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157:493–505CrossRefPubMed Gorman JM, Kent JM, Sullivan GM, Coplan JD (2000) Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157:493–505CrossRefPubMed
27.
Zurück zum Zitat Gorman JM, Liebowitz MR, Fyer AJ, Stein J (1989) A neuroanatomical hypothesis for panic disorder. Am J Psychiatry 146:148–161PubMed Gorman JM, Liebowitz MR, Fyer AJ, Stein J (1989) A neuroanatomical hypothesis for panic disorder. Am J Psychiatry 146:148–161PubMed
28.
Zurück zum Zitat Guy W (1976) Clinical global impression. In: Guy W (ed) ECDEU assessment manual for psychopharmacology, revised. National Insitute of Mental Health, Rockville, pp 217–222 Guy W (1976) Clinical global impression. In: Guy W (ed) ECDEU assessment manual for psychopharmacology, revised. National Insitute of Mental Health, Rockville, pp 217–222
29.
Zurück zum Zitat Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50–55PubMed Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50–55PubMed
30.
Zurück zum Zitat Hayes SC (2008) Climbing our hills: a beginning conversation on the comparison of acceptance and commitment therapy and traditional cognitive behavioral therapy. Clin Psychol Sci Pract 15:286–295 Hayes SC (2008) Climbing our hills: a beginning conversation on the comparison of acceptance and commitment therapy and traditional cognitive behavioral therapy. Clin Psychol Sci Pract 15:286–295
31.
Zurück zum Zitat Hofmann SG, Alpers GW, Pauli P (2009) Phenomenology of panic and phobic disorders. In: Antony MM, Stein MB (eds) Oxford handbook of anxiety and related disorders. Oxford University Press, New York, pp 34–46 Hofmann SG, Alpers GW, Pauli P (2009) Phenomenology of panic and phobic disorders. In: Antony MM, Stein MB (eds) Oxford handbook of anxiety and related disorders. Oxford University Press, New York, pp 34–46
32.
Zurück zum Zitat Hueweler R, Kandil FI, Alpers GW, Gerlach AL (2009) The impact of visual flow stimuli on anxiety, dizziness, and body sway in persons with and without fear of heights. Behav Res Therapy 47:345–352CrossRef Hueweler R, Kandil FI, Alpers GW, Gerlach AL (2009) The impact of visual flow stimuli on anxiety, dizziness, and body sway in persons with and without fear of heights. Behav Res Therapy 47:345–352CrossRef
33.
Zurück zum Zitat Koch EI, Gloster AT, Waller SA (2007) Exposure treatments for panic disorder with and without agoraphobia. In: Richard DCS, Lauterbach DL (eds) Handbook of exposure therapies. Elsevier, Burlington, pp 221–245 Koch EI, Gloster AT, Waller SA (2007) Exposure treatments for panic disorder with and without agoraphobia. In: Richard DCS, Lauterbach DL (eds) Handbook of exposure therapies. Elsevier, Burlington, pp 221–245
34.
Zurück zum Zitat Lang T, Helbig-Lang S, Westphal D, Gloster AT, Wittchen HU (2009) Kognitiv-behaviorale Behandlung der Panikstörung mit Agoraphobie. Ein Therapiemanual. Hogrefe, Göttingen Lang T, Helbig-Lang S, Westphal D, Gloster AT, Wittchen HU (2009) Kognitiv-behaviorale Behandlung der Panikstörung mit Agoraphobie. Ein Therapiemanual. Hogrefe, Göttingen
35.
Zurück zum Zitat Lonsdorf TB, Weike AI, Nikamo P, Schalling M, Hamm AO, Öhman A (2009) Genetic gating of human fear learning and extinction–Possible implications for gene-environment interaction in anxiety disorder. Psychol Sci 20:198–206CrossRefPubMed Lonsdorf TB, Weike AI, Nikamo P, Schalling M, Hamm AO, Öhman A (2009) Genetic gating of human fear learning and extinction–Possible implications for gene-environment interaction in anxiety disorder. Psychol Sci 20:198–206CrossRefPubMed
36.
Zurück zum Zitat McHugh RK, Smits JAJ, Otto MW (2009) Empirically supported treatments for panic disorder. Psychiatr Clin North Am McHugh RK, Smits JAJ, Otto MW (2009) Empirically supported treatments for panic disorder. Psychiatr Clin North Am
37.
Zurück zum Zitat Melzig CA, Michalowski JM, Holtz K, Hamm AO (2008) Anticipation of interoceptive threat in highly anxiety sensitive persons. Behav Res Ther 46:1126–1134CrossRefPubMed Melzig CA, Michalowski JM, Holtz K, Hamm AO (2008) Anticipation of interoceptive threat in highly anxiety sensitive persons. Behav Res Ther 46:1126–1134CrossRefPubMed
38.
Zurück zum Zitat Neudeck P, Wittchen H-U (2005) Die Vernachlässigung der Expositionsverfahren- ein Verstoß gegen die Regeln der Kunst!. In: Neudeck P, Wittchen H-U (eds) Konfrontationstherapie bei psychischen Störungen. Hogrefe, Göttingen, pp 7–14 Neudeck P, Wittchen H-U (2005) Die Vernachlässigung der Expositionsverfahren- ein Verstoß gegen die Regeln der Kunst!. In: Neudeck P, Wittchen H-U (eds) Konfrontationstherapie bei psychischen Störungen. Hogrefe, Göttingen, pp 7–14
39.
Zurück zum Zitat Rabin R, de Charro F (1999, 2001) EQ-5D: a measure of health status from the EuroQol Group. Paper presented at the 12th Medical Symposium of the Yrjo-Jahnsson-Foundation, Finland Rabin R, de Charro F (1999, 2001) EQ-5D: a measure of health status from the EuroQol Group. Paper presented at the 12th Medical Symposium of the Yrjo-Jahnsson-Foundation, Finland
40.
Zurück zum Zitat Radomsky AS, Rachman S, Thordarsona DS, McIsaaca HK, Teachman BA (1999) The claustrophobia questionnaire. J Anxiety Disord 15:287–297CrossRef Radomsky AS, Rachman S, Thordarsona DS, McIsaaca HK, Teachman BA (1999) The claustrophobia questionnaire. J Anxiety Disord 15:287–297CrossRef
41.
Zurück zum Zitat Reiss S, Peterson RA, Gursky DM, McNally RJ (1986) Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Therapy 24:1–8CrossRef Reiss S, Peterson RA, Gursky DM, McNally RJ (1986) Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Therapy 24:1–8CrossRef
42.
Zurück zum Zitat Richard DCS, Lauterbach D, Gloster AT (2007) Description, mechanisms of action, and assessment. In: Richard DCS, Lauterbach DL (eds) Handbook of exposure therapies. Elsevier, Burlington, pp 1–28CrossRef Richard DCS, Lauterbach D, Gloster AT (2007) Description, mechanisms of action, and assessment. In: Richard DCS, Lauterbach DL (eds) Handbook of exposure therapies. Elsevier, Burlington, pp 1–28CrossRef
43.
Zurück zum Zitat Shadish WR, Cook TD, Campbell DT (2002) Experimental and quasi-experimental designs for generalized causal inference. Houghton-Mifflin, Boston Shadish WR, Cook TD, Campbell DT (2002) Experimental and quasi-experimental designs for generalized causal inference. Houghton-Mifflin, Boston
44.
Zurück zum Zitat Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW et al (2001) Reliability and validity of a structured interview guide for the Hamilton anxiety rating scale (SIGH-A). Depress Anxiety 13(4):166–178CrossRefPubMed Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW et al (2001) Reliability and validity of a structured interview guide for the Hamilton anxiety rating scale (SIGH-A). Depress Anxiety 13(4):166–178CrossRefPubMed
45.
Zurück zum Zitat Sheehan DV (1983) The anxiety disease. Charles Scribner’s Sons, New York Sheehan DV (1983) The anxiety disease. Charles Scribner’s Sons, New York
46.
Zurück zum Zitat Wittchen H-U, Gloster AT (2009) Developments in the treatment and diagnosis of anxiety disorders. Psychiatr Clin North Am 32:xix–xiii Wittchen H-U, Gloster AT (2009) Developments in the treatment and diagnosis of anxiety disorders. Psychiatr Clin North Am 32:xix–xiii
47.
Zurück zum Zitat Wittchen H-U, Pfister H (1997) DIA-X Interview. Instruktionsmanual zur Durchführung von DIA-X-Interviews (Instruction manual for the DIA-X-Interview). Swets & Zeitlinger, Frankfurt Wittchen H-U, Pfister H (1997) DIA-X Interview. Instruktionsmanual zur Durchführung von DIA-X-Interviews (Instruction manual for the DIA-X-Interview). Swets & Zeitlinger, Frankfurt
Metadaten
Titel
Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia
verfasst von
A. T. Gloster
H. U. Wittchen
F. Einsle
M. Höfler
T. Lang
S. Helbig-Lang
T. Fydrich
L. Fehm
A. O. Hamm
J. Richter
G. W. Alpers
A. L. Gerlach
A. Ströhle
T. Kircher
J. Deckert
P. Zwanzger
V. Arolt
Publikationsdatum
01.11.2009
Verlag
D. Steinkopff-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe Sonderheft 2/2009
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-009-0065-6

Weitere Artikel der Sonderheft 2/2009

European Archives of Psychiatry and Clinical Neuroscience 2/2009 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.